Literature DB >> 21917273

Gender differences in Wilson's disease.

T Litwin1, G Gromadzka, A Członkowska.   

Abstract

BACKGROUND: Wilson's disease (WD) is an inherited disorder of copper metabolism. Although well documented in many disorders, gender hasn't been directly addressed in WD; therefore, our aim was to evaluate gender differences in WD.
METHODS: We analyzed data on 627 consecutive WD patients entered into our registry (1958-2010).
RESULTS: We observed a male predominance in our population of WD patients (327 males vs. 290 females; p<0.05). At disease diagnosis, 510/627 patients were symptomatic, most patients had the neuropsychiatric WD form (345/510; p<0.01). The neuropsychiatric form occurred predominantly in men versus women (209/278 vs. 136/232; p<0.01), especially the rigidity-tremor (71/111 vs. 40/111; p<0.05), rigidity (23/33 vs. 10/33; p=0.07) and psychiatric forms (46/71 vs. 25/71; p=0.06). The hepatic form occurred more frequently in women (96/165 vs. 69/165; p<0.01) and women developed the neuropsychiatric form 2 years later than men (29.4 vs. 27.1; p<0.05).
CONCLUSIONS: According to our findings, the neuropsychiatric form of WD is predominant at diagnosis in both genders. The hepatic form of WD occurs more frequently in women, and women develop the neuropsychiatric form of disease almost 2 years later than men. We speculate these differences may be due to the protective effect of estrogens and iron metabolism differences.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21917273     DOI: 10.1016/j.jns.2011.08.028

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  37 in total

1.  Report of the ASFA apheresis registry study on Wilson's disease.

Authors:  Huy P Pham; Joseph Schwartz; Laura Cooling; Jan C Hofmann; Haewon C Kim; Shanna Morgan; Monica B Pagano; Jennifer Schneiderman; Jeffrey L Winters; Chisa Yamada; Edward C C Wong; Yanyun Wu
Journal:  J Clin Apher       Date:  2015-08-14       Impact factor: 2.821

Review 2.  Encephalopathy in Wilson disease: copper toxicity or liver failure?

Authors:  Peter Ferenci; Tomasz Litwin; Joanna Seniow; Anna Czlonkowska
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

3.  Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes.

Authors:  Jennifer Guy; Marion G Peters
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-10

Review 4.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

Review 5.  Genetics and epigenetic factors of Wilson disease.

Authors:  Valentina Medici; Janine M LaSalle
Journal:  Ann Transl Med       Date:  2019-04

Review 6.  Challenges in the diagnosis of Wilson disease.

Authors:  Aurélia Poujois; France Woimant
Journal:  Ann Transl Med       Date:  2019-04

7.  Association of dopamine receptor gene polymorphisms with the clinical course of Wilson disease.

Authors:  T Litwin; G Gromadzka; J Samochowiec; A Grzywacz; A Członkowski; A Członkowska
Journal:  JIMD Rep       Date:  2012-07-06

8.  Wilson disease: At the crossroads between genetics and epigenetics-A review of the evidence.

Authors:  Dorothy A Kieffer; Valentina Medici
Journal:  Liver Res       Date:  2017-08-16

Review 9.  Copper and the brain noradrenergic system.

Authors:  Svetlana Lutsenko; Clorissa Washington-Hughes; Martina Ralle; Katharina Schmidt
Journal:  J Biol Inorg Chem       Date:  2019-11-05       Impact factor: 3.358

10.  Osteoporosis and bone mineral density in patients with Wilson's disease: a systematic review and meta-analysis.

Authors:  J Chenbhanich; C Thongprayoon; A Atsawarungruangkit; T Phupitakphol; W Cheungpasitporn
Journal:  Osteoporos Int       Date:  2017-11-06       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.